Covid-19 drug studies could highlight speed, flexibility and reduced risk of virtual clinical trials
The speed, flexibility and strong risk-benefit ratio of virtual clinical trials could all be highlighted in the assessment of potential…
The speed, flexibility and strong risk-benefit ratio of virtual clinical trials could all be highlighted in the assessment of potential…
The speed, flexibility and strong risk-benefit ratio of virtual clinical trials could all be highlighted in the assessment of potential…
Like many firms in the pharmaceutical sector, Regeneron has turned a great deal of attention towards the fight against Covid-19…
Like many firms in the pharmaceutical sector, Regeneron has turned a great deal of attention towards the fight against Covid-19…
In its attempt to provide treatments for Covid-19 patients, American biopharma firm FibroGen has chosen to tackle the infection slightly…
In its attempt to provide treatments for Covid-19 patients, American biopharma firm FibroGen has chosen to tackle the infection slightly…
On the vaccine front, American biotech firm Moderna was one of the first companies in the world to react to…
On the vaccine front, American biotech firm Moderna was one of the first companies in the world to react to…
Social responsibility may be a key reason why researchers are still conducting trials for chloroquine as a Covid-19 treatment despite…
Social responsibility may be a key reason why researchers are still conducting trials for chloroquine as a Covid-19 treatment despite…